Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Peter Campochiaro, MD"
3
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT00407355
Completed
Phase 1/2
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
Genentech, Inc.
ClinicalTrials.gov
NCT00407355
Completed
Phase 1/2
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
Genentech, Inc.
NCT01003106
Completed
Phase 1/2
Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions
Genentech, Inc.
ClinicalTrials.gov
NCT01003106
Completed
Phase 1/2
Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions
Genentech, Inc.
NCT01198327
Completed
Phase 3
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion
Genentech, Inc.
ClinicalTrials.gov
NCT01198327
Completed
Phase 3
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion
Genentech, Inc.
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease